Insulin Pump Market - 2024-2033

July 2025 | 217 pages | ID: I70F250B93B8EN
DataM Intelligence

Abstracts

The Insulin Pump Market was valued at US$ 6.51 billion in 2024 and is anticipated to reach US$ 13.11 billion by 2033, at a CAGR of 0.083 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Insulin Pump Market.

This report delivers a comprehensive overview of the Insulin Pump Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Insulin Pump Market. The Insulin Pump Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Insulin Pump Market Scope:

By Type

• Patch Pumps
• Tethered Pumps

By Product

• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• My Life Omnipod
• Others

By Accessories

• Insulin Reservoirs or Cartridges
• Insulin Set Insertion Devices
• Batteries

By Disease Indication

• Type 1 Diabetes
• Type 2 Diabetes

By End-User

• Hospitals
• Specialty Clinics
• Homecare
• Others

Key Players

• Medtronic
• Roche
• Tandem Diabetes Care, Inc.
• Insulet Corporation.
• Ypsomed AG
• Novo Nordisk
• SOOIL Developments Co., Ltd
• Johnson & Johnson Services, Inc. LIST NOT EXHAUSTIVE

Major Highlights

This report delivers a comprehensive overview of the Insulin Pump Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Insulin Pump Market. The Insulin Pump Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Type
3.2. Snippet by Product
3.3. Snippet by Accessories
3.4. Snippet by Disease Indication
3.5. Snippet by End-User
3.6. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. High Prevalence of Diabetes and Associated Disorders
    4.1.1.2. XX
  4.1.2. Restraints
    4.1.2.1. High Cost of Insulin Pumps
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

5.1. Market Leaders and Pioneers
5.2. Emerging Pioneers and Prominent Players
5.3. Established leaders with largest largest-selling Brand
5.4. Market leaders with established Product
5.5. CXO Perspectives
5.6. Latest Developments and Breakthroughs
5.7. Case Studies/Ongoing Research
5.8. Regulatory and Reimbursement Landscape
5.9. North America
5.10. Europe
5.11. Asia Pacific
5.12. Latin America
5.13. Middle East & Africa
5.14. Porter’s Five Force Analysis
5.15. Supply Chain Analysis
5.16. Patent Analysis
5.17. SWOT Analysis
5.18. Unmet Needs and Gaps
5.19. Recommended Strategies for Market Entry and Expansion
5.20. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
5.21. Pricing Analysis and Price Dynamics
5.22. Key Opinion Leaders

6. BY TYPE

6.1. Introduction
  6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
  6.1.2. Market Attractiveness Index, By Type
6.2. Patch Pumps *
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Tethered Pumps

7. BY PRODUCT

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  7.1.2. Market Attractiveness Index, By Product
7.2. MiniMed*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Accu-Chek
7.4. Tandem
7.5. Omnipod
7.6. My Life Omnipod
7.7. Others

8. BY ACCESSORIES

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Accessories
  8.1.2. Market Attractiveness Index, By Accessories
8.2. Insulin Reservoirs or Cartridges*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Insulin Set Insertion Devices
8.4. Batteries

9. BY DISEASE INDICATION

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication
  9.1.2. Market Attractiveness Index, By Disease Indication
9.2. Type 1 Diabetes*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Type 2 Diabetes

10. BY END-USER

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty Clinics
10.4. Homecare
10.5. Others

11. BY REGION

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Accessories
  11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication
  11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.2.8.1. U.S.
    11.2.8.2. Canada
    11.2.8.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Accessories
  11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication
  11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.3.8.1. Germany
    11.3.8.2. U.K.
    11.3.8.3. France
    11.3.8.4. Spain
    11.3.8.5. Italy
    11.3.8.6. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Accessories
  11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication
  11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.4.8.1. Brazil
    11.4.8.2. Argentina
    11.4.8.3. Rest of South America
11.5. Asia-Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Accessories
  11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication
  11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.5.8.1. China
    11.5.8.2. India
    11.5.8.3. Japan
    11.5.8.4. South Korea
    11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Accessories
  11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication
  11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. COMPETITIVE LANDSCAPE

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. COMPANY PROFILES

13.1. Medtronic*
  13.1.1. Company Overview
  13.1.2. Product Portfolio
    13.1.2.1. Product Description
    13.1.2.2. Product Key Performance Indicators (KPIs)
    13.1.2.3. Historic and Forecasted Product Sales
    13.1.2.4. Product Sales Volume
  13.1.3. Financial Overview
    13.1.3.1. Company Revenue’s
    13.1.3.2. Geographical Revenue Shares
    13.1.3.3. Revenue Forecasts
  13.1.4. Key Developments
    13.1.4.1. Mergers & Acquisitions
    13.1.4.2. Key Product Development Activities
    13.1.4.3. Regulatory Approvals etc.
  13.1.5. SWOT Analysis
13.2. Roche
13.3. Tandem Diabetes Care, Inc.
13.4. Insulet Corporation.
13.5. Ypsomed AG
13.6. Novo Nordisk
13.7. SOOIL Developments Co., Ltd
13.8. Johnson & Johnson Services, Inc. LIST NOT EXHAUSTIVE

14. APPENDIX

14.1. About Us and Services
14.2. Contact Us